Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2006 | Volume: 2 | Issue: 3 | Page No.: 352-356
DOI: 10.3923/ijp.2006.352.356
Amenorrhea: An Advantage Rather than a Complication of Depot Medroxy Progesterone Acetate Injectable Contraceptive
H. Sadeghi-Bazargani and Z. Fardyazar

Abstract:
In part of a vast longitudinal multi-centric research program being conducted about menstrual complications of DMPA in northwestern Iran, we studied the satisfaction and personal ideas of 411 amenorrheatic DMPA users about bleeding loss and amenorrhea caused by DMPA and effect of these ideas on its acceptability. Of those 411 persons who didn`t have even one day of menstruation one month after injection, 360 didn`t have even one day of menstruation after 60 days. These people were asked if they were satisfied with menstrual cessation caused by DMPA injection or not? 73.4% of participants declared their satisfaction with this complication of DMPA. No statistically significant difference was shown between type of menstrual pattern and weight, previous history of irregular menses and previous history of abortion. But breastfeeding and a history of cesarean section affected the menstrual pattern during the month after a DMPA injection. 57.5% of women very satisfied with amenorrhea caused by DMPA compared with 5.7% of those very dissatisfied with it, continued to use DMPA at least for six months.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

H. Sadeghi-Bazargani and Z. Fardyazar , 2006. Amenorrhea: An Advantage Rather than a Complication of Depot Medroxy Progesterone Acetate Injectable Contraceptive. International Journal of Pharmacology, 2: 352-356.

DOI: 10.3923/ijp.2006.352.356

URL: https://scialert.net/abstract/?doi=ijp.2006.352.356

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom